CIK 0000109657 · Non-accelerated filer<br>Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 941620407
- Phone
- (800) 304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2006-10-12 | HAUSMAN MARVIN S MD President & CEO | Grant or award | +330,769 | $0.20 | $67K | 330,769 |
| 2006-08-01 | CENTRON MICHAEL D VP & CFO | Grant or award · Incentive Stock Option (right to buy) | +100,000 | 250,000 | ||
| 2006-08-01 | REPINE JOHN E Director | Grant or award · Non-Qualified Stock Option | +5,000 | 67,400 | ||
| 2006-08-01 | HAUSMAN MARVIN S MD Director | Grant or award · Non-Qualified Stock Option | +5,000 | 714,695 | ||
| 2006-08-01 | NEILL SYDNEY COLIN Director | Grant or award · Non-Qualified Stock Option (right to buy) | +5,000 | 240,000 | ||
| 2006-08-01 | Post Gary M Director | Grant or award · Non-Qualified Stock Option (right to buy) | +5,000 | 35,000 | ||
| 2006-05-12 | Post Gary M Director | Purchase · Common Stock Warrant (right to buy) | +108,000 | 108,000 | ||
| 2005-12-28 | REPINE JOHN E Director | Grant or award · Non-Statutory Stock Option (right to purchase) | +30,000 | $0.29 | $9K | 62,400 |
| 2005-12-28 | RODELL TIMOTHY C JR Director | Grant or award · Non-Statutory Stock Option (right to purchase) | +100,000 | $0.29 | $29K | 455,237 |
| 2005-12-28 | NEILL SYDNEY COLIN Director | Grant or award · Non-Statutory Stock Option (right to buy) | +100,000 | $0.29 | $29K | 235,000 |
| 2005-12-28 | HAUSMAN MARVIN S MD Director | Grant or award · Non-Statutory Stock Option (right to purchase) | +500,000 | $0.29 | $145K | 709,695 |
| 2005-12-28 | Guillen Steven T President & CEO | Grant or award · Non-Statutory Stock Option (right to buy) | +500,000 | $0.29 | $145K | 1,100,000 |
| 2005-10-05 | HAUSMAN MARVIN S MD Interim CFO | Grant or award · Non-Statutory Stock Option (Right to Buy) | +108,000 | $0.37 | $40K | |
| 2005-06-22 | HAUSMAN MARVIN S MD Chairman & Interim CFO | Grant or award · Stock Option Grant (right to buy) | +5,000 | $0.34 | $2K | 101,695 |
| 2005-06-22 | NEILL SYDNEY COLIN Director | Grant or award · stock option (right to buy) | +5,000 | $0.34 | $2K | 135,000 |
| 2005-06-22 | RODELL TIMOTHY C JR Director | Grant or award · stock option (right to buy) | +5,000 | $0.34 | $2K | 355,237 |
| 2005-02-28 | Guillen Steven T President & CEO | Grant or award | +600,000 | $0.40 | $240K | 600,000 |
| 2005-02-28 | Guillen Steven T President & CEO | Grant or award · Stock Option-Right to buy (ISO) | +500,000 | $0.40 | $200K | 1,100,000 |
| 2005-02-28 | Guillen Steven T President & CEO | Grant or award · Stock Option-Right to buy (NQSO) | +100,000 | $0.40 | $40K | 1,200,000 |
| 2004-12-24 | ODonnell Manus H Acting Chief Operating Officer | Grant or award · Stock Option-Right to Buy | +100,000 | $0.59 | $59K | 100,000 |
Page 7 of 9 · 164 trades